A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, methodical progress are beginning to add up. November is Pancreatic Cancer ...

KRAS inhibitors, cancer vaccines, and cell therapies are promising advancements in pancreatic cancer treatment, potentially improving patient outcomes. Innovative drug delivery techniques aim to ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immune system ...

Carolyn Gusoff has covered some of the most high profile news stories in the New York City area and is best known as a trusted, tenacious, consistent and caring voice of Long Island's concerns. For ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

A team of researchers at the Georgetown University Lombardi Comprehensive Cancer Center published new research exploring causes and potential treatment methods for pancreatic cancer, Lombardi ...

Inform future clinical development plans, further establishing elraglusib as a potential backbone therapy in ...

Treating pancreatic cancer remains one of oncology’s greatest challenges. The disease is often diagnosed at an advanced stage, progresses rapidly, and responds poorly to existing treatments.

Former U.S. Sen. Ben Sasse of Nebraska announced this week that he has been diagnosed with metastatic stage 4 pancreatic cancer, calling the disease "a death sentence" in a message posted on X. Sasse, ...